Global Radiofrequency Ablation Devices Market Share Is Expected To Grow At A CAGR Of 11% By 2030

20-Jan-2023 | Facts and Factors

According to Facts and Factors, the global radiofrequency ablation devices market size was worth around USD 3.59 billion in 2021 and is predicted to grow to around USD 10.21 billion by 2030 with a compound annual growth rate (CAGR) of roughly 11% between 2022 and 2030.

Radiofrequency ablation (RFA) is a medical procedure that uses heat energy to relieve pain or decrease the size of the tumor and other growth in the body. The process is used to treat a variety of medical conditions including malignant or benign tumors, chronic neck or back pain, and chronic venous insufficiency observed in legs. The process is extremely similar to needle biopsy and requires the insertion of a needle-like probe in the patient’s body. Once the device is firmly and accurately inserted, radiofrequency waves are sent starting from the probe to the surrounding tissue in the intended area. This leads to the death of the nearby cells.

Browse the full “Radiofrequency Ablation Devices Market Size, Share, Growth Analysis Report By Application (Cardiology & Cardiac Rhythm Management, Surgical Oncology, Cosmetology, and Gynecology), By Type (Bipolar Radiofrequency Ablation and Unipolar Radiofrequency Ablation), By Product (Disposables, RF Generators, and Reusables), By End-User (Ambulatory Surgical Centers, Hospitals, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" report at https://www.fnfresearch.com/radiofrequency-ablation-devices-market

Once the cells are dead, the immunity system starts removing them from the system causing an internal reaction and resulting in shrinkage of the nodule size. To place the tip of the probe at the correct point, various supportive devices are used like imaging techniques or ultrasound. The technique is patient friendly since it is minimally invasive, does not require long postoperative time, and can be conducted in a normal hospital setting or in the comfort of the patient's home. Once the process is successfully carried out, the patient can carry out daily functions within 24 hours.

The global radiofrequency ablation devices market is projected to grow owing to the increasing number of cancer patients resulting in a rise in research & development and investments in cancer treatments. The RFA technique is mostly used to treat cancer related to the kidney, lungs, liver, adrenal gland, thyroid, and pancreas.

However, the treatment is recommended for cancer patients only when they are not suitable for operational procedures like high-risk patients. Cancer is currently one of the leading causes of death in humans. The medical condition does not have a permanent cure and the medical sector is investing in developing the right cure for the disease. Until a full-proof treatment plan is developed, healthcare professionals use different ways to eliminate or manage cancer cells.

One of the limited but effective methods is the RFA procedure. The radiologist working on the patient used an imaging test to zero down on the specific site where the probe is inserted into the cancer tissue. The global market could further develop owing to the increasing approvals from regional regulatory bodies like the US Food and Drugs Administration and the European Commission for allowing new discoveries and innovations to be used on the patient without serious side effects.

The global market could register growth limitations due to the unawareness of the RFA method in various developing and underdeveloped nations. Most countries lack the necessary supportive healthcare infrastructure which results in the cost of the devices and the treatment plan soaring extremely high. The problem can only be resolved if there are global efforts toward making quality healthcare accessible to all.

The growing product innovation may provide growth opportunities while the postoperative complications could act as a major challenge.

Segmental Overview 

The global radiofrequency ablation devices market is segmented based on application, type, product, end-user, and region.

Based on product, the global market divisions are disposables, RF generators, and reusables. In 2021, the global market registered the highest growth in the disposables market segment. Various factors are leading the segmental growth. Some of them are the ease of providing care in outpatient settings along with a decrease in morbidity and mortality rates due to RF devices. Disposable products are easier to use because the chances of infection are less with these devices.

For instance, the probe used in the RFA process is needle-like and has to be discarded at every use to avoid the spread of infection. The growing number of arthritis patients could lead to higher demand for the products. Over 2% of the Australian population suffers from rheumatoid arthritis.

Based on end-user, the global market divisions are ambulatory surgical centers, hospitals, and others. The global market is projected to be led by the hospitals segment during the forecast period due to the increasing number of patients. The growth in cancer cases and sections of the population suffering from back and neck pain are projected to drive segmental growth. Poor lifestyle habits, incorrect sitting & standing posture, aging, and other medical conditions are leading causes of back pain which is observed in almost 16 million adults.

Regional Overview

North America is projected to register the highest growth in the global radiofrequency ablation devices market due to the increasing use of the technique to treat patients. The regional growth may also be driven by the growing number of players supplying products domestically or expanding the consumer database in the international market.

Rampant product innovation, strategic collaborations, and entry into less exposed countries in combination are helping the region generate a high CAGR. Growth in Asia-Pacific is subjected to the rise in healthcare investments as well as growing accessibility to quality medical care in countries like Japan, India, China, and South Korea.

Report Scope

Competitive Landscape

The global radiofrequency ablation devices market is led by Sutter Medizintechnik Gmbh, AtriCure, C. R. Bard, Inomed Medizintechnik GmbH, Epimed International, and Arthrex amongst others.

Recent Developments:

• In January 2021, Medtronic announced the approval from the FDA for itsDiamondTemp Ablation Catheters – P200028
• In October 2021, Venclose Inc obtained FDA approval for Maven endovenous radiofrequency ablation (RFA) catheter

The global radiofrequency ablation devices market is segmented as follows:

By Application

• Cardiology & Cardiac Rhythm Management
• Surgical Oncology
• Cosmetology
• Gynecology

By Type

• Bipolar Radiofrequency Ablation
• Unipolar Radiofrequency Ablation

By Product

• Disposables
• RF Generators
• Reusables

By End-User

• Ambulatory Surgical Centers
• Hospitals
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com